MYBL2 and neoplasm: The expected model size with the highest performance level consists of 10 of the most robust predictive variables and is comprised of four clinico-pathological variables and six additional proteins: nodal status, tumor size, AURKA, BCL2, age, CD68, HER2, MYBL2, CCNB1 and GSTM1.